Ardelyx Inc
Biotechnology
Healthcare
ARDX
236 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.24
52 week high
7.57
high
4.62
52 week low
4.33
low
4.02
growth
-34.40 %
previous Close
4.33
P/E ratio
market cap
1.14 B
div yield
0
usd
Sep 2024
qoq
revenue
98.24 M
34.17 %
net incoming
-809.00 K
95.08 %
eps
0.00 %
95.14 %
eps surprise
93.20 %
net profit margin
-0.82 %
21.00 %
operating incoming
2.23 M
116.38 %
net change in cash
5.54 M
-3.55 %
cash on hand
47.43 M
13.22 %
cost of revenue
15.73 M
57.20 %
top top